ChemoMetec A/S updated earnings guidance for the fiscal year 2022/2023. For the year, the company expected revenue of DKK 430 million - DKK 460 million, against the previous guidance of DKK 485 million-DKK 505 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
351.6 DKK | -2.06% | -2.17% | -9.38% |
May. 27 | Denmark's ChemoMetec Appoints New CFO | MT |
May. 24 | ChemoMetec A/S Announces CFO Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.38% | 909M | |
+75.56% | 12.55B | |
-23.35% | 7.51B | |
+8.51% | 6.74B | |
+14.95% | 5.48B | |
-14.65% | 4.93B | |
+30.59% | 4.71B | |
-25.40% | 3.83B | |
-22.61% | 2.9B | |
+49.50% | 2.49B |
- Stock Market
- Equities
- CHEMM Stock
- News ChemoMetec A/S
- ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023